Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Baum

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
Plos One|February 6, 2013
Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitorsArianna Moiani, Annarita Miccio, Ermanno Rizzi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2003
Engineered long terminal repeats of retroviral vectors enhance transgene expression in hepatocytes in vitro and in vivoKanji Yamaguchi, Katsuhiko Itoh, Naoki Ohnishi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Protein transduction from retroviral Gag precursorsChristine Voelkel, Melanie Galla, Tobias Maetzig, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2009
Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control regionParitha I Arumugam, Tomoyasu Higashimoto, Fabrizia Urbinati, et al.
Human Gene Therapy|June 18, 2005
Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cellsAurelio Lorico, Daniel Bratbak, Johann Meyer, et al.
Blood|October 31, 2002
High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiationBernhard Schiedlmeier, Hannes Klump, Elke Will, et al.
Science (New York, N.Y.)|May 21, 2005
Clonal dominance of hematopoietic stem cells triggered by retroviral gene markingOlga Kustikova, Boris Fehse, Ute Modlich, et al.
Cell Cycle (Georgetown, Tex.)|December 17, 2005
HOXB4 inhibits cell growth in a dose-dependent manner and sensitizes cells towards extrinsic cuesElke Will, Daniel Speidel, Zheng Wang, et al.
Journal of Virology|December 25, 2003
Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptidesMarc Egelhofer, Gunda Brandenburg, Holger Martinius, et al.
Experimental Hematology|May 2, 2006
Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical researchAxel Schambach, Melanie Galla, Ute Modlich, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Plos One|February 6, 2013
Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitorsArianna Moiani, Annarita Miccio, Ermanno Rizzi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 6, 2003
Engineered long terminal repeats of retroviral vectors enhance transgene expression in hepatocytes in vitro and in vivoKanji Yamaguchi, Katsuhiko Itoh, Naoki Ohnishi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2010
Protein transduction from retroviral Gag precursorsChristine Voelkel, Melanie Galla, Tobias Maetzig, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2009
Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control regionParitha I Arumugam, Tomoyasu Higashimoto, Fabrizia Urbinati, et al.
Human Gene Therapy|June 18, 2005
Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cellsAurelio Lorico, Daniel Bratbak, Johann Meyer, et al.
Blood|October 31, 2002
High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiationBernhard Schiedlmeier, Hannes Klump, Elke Will, et al.
Science (New York, N.Y.)|May 21, 2005
Clonal dominance of hematopoietic stem cells triggered by retroviral gene markingOlga Kustikova, Boris Fehse, Ute Modlich, et al.
Cell Cycle (Georgetown, Tex.)|December 17, 2005
HOXB4 inhibits cell growth in a dose-dependent manner and sensitizes cells towards extrinsic cuesElke Will, Daniel Speidel, Zheng Wang, et al.
Journal of Virology|December 25, 2003
Inhibition of human immunodeficiency virus type 1 entry in cells expressing gp41-derived peptidesMarc Egelhofer, Gunda Brandenburg, Holger Martinius, et al.
Experimental Hematology|May 2, 2006
Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical researchAxel Schambach, Melanie Galla, Ute Modlich, et al.
Pageof 15